Clover Health to Report Third Quarter 2024 Financial Results on November 6
Clover Health (Nasdaq: CLOV) announced it will release its third quarter 2024 financial results after market close on Wednesday, November 6, 2024. The company will host a conference call and webcast at 5:00 p.m. Eastern Time the same day to discuss the results. U.S. participants can dial 800-579-2543, while international callers should use 785-424-1789, with conference ID CLOVQ324. The webcast will be available on Clover Health's Investor Relations website for 12 months.
Clover Health (Nasdaq: CLOV) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato mercoledì 6 novembre 2024. L'azienda terrà una conferenza telefonica e un webcast alle 17:00 ora orientale dello stesso giorno per discutere i risultati. I partecipanti degli Stati Uniti possono comporre il numero 800-579-2543, mentre i chiamanti internazionali dovrebbero utilizzare il numero 785-424-1789, con ID conferenza CLOVQ324. Il webcast sarà disponibile sul sito delle Relazioni con gli Investitori di Clover Health per 12 mesi.
Clover Health (Nasdaq: CLOV) anunció que publicará sus resultados financieros del tercer trimestre de 2024 después del cierre del mercado el miércoles 6 de noviembre de 2024. La compañía llevará a cabo una conferencia telefónica y un webcast a las 5:00 p.m. Hora del Este el mismo día para discutir los resultados. Los participantes de EE. UU. pueden marcar el 800-579-2543, mientras que los llamantes internacionales deben usar el 785-424-1789, con el ID de conferencia CLOVQ324. El webcast estará disponible en el sitio web de Relaciones con Inversores de Clover Health durante 12 meses.
Clover Health (Nasdaq: CLOV)는 2024년 11월 6일 수요일 시장 폐장 후 2024년 3분기 재무 결과를 발표할 것이라고 발표했습니다. 회사는 같은 날 동부 표준시 오후 5시부터 결과를 논의하기 위한 전화 회의 및 웹캐스트를 진행합니다. 미국 참가자는 800-579-2543으로 전화할 수 있으며, 국제 전화자는 785-424-1789을 사용해야 하며, 회의 ID는 CLOVQ324입니다. 웹캐스트는 Clover Health의 투자자 관계 웹사이트에서 12개월 동안 이용할 수 있습니다.
Clover Health (Nasdaq: CLOV) a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 après la clôture des marchés le mercredi 6 novembre 2024. L'entreprise organisera un appel conférence et un webcast à 17h00, heure de l'Est, le même jour pour discuter des résultats. Les participants américains peuvent composer le 800-579-2543, tandis que les appelants internationaux doivent utiliser le 785-424-1789, avec l'identifiant de la conférence CLOVQ324. Le webcast sera disponible sur le site des relations avec les investisseurs de Clover Health pendant 12 mois.
Clover Health (Nasdaq: CLOV) hat angekündigt, dass die Finanzergebnisse des dritten Quartals 2024 nach Börsenschluss am Mittwoch, den 6. November 2024, veröffentlicht werden. Das Unternehmen wird am selben Tag um 17:00 Uhr Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen. Teilnehmer aus den USA können die Nummer 800-579-2543 wählen, während internationale Anrufer 785-424-1789 nutzen sollten, mit der Konferenz-ID CLOVQ324. Der Webcast wird 12 Monate lang auf der Unternehmenswebsite für Investoren von Clover Health verfügbar sein.
- None.
- None.
FRANKLIN, Tenn., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), today announced that it will report third quarter 2024 financial results after market close on Wednesday, November 6, 2024. Management will host a conference call and webcast at 5:00 p.m. Eastern Time on November 6, 2024, to discuss Clover Health’s third quarter 2024 business and financial results.
Third Quarter 2024 Conference Call and Webcast Details:
- What: Clover Health’s Third Quarter 2024 Earnings Conference Call
- When: Wednesday, November 6, 2024, at 5:00 p.m. Eastern Time
- Dial In: To access the call via telephone please dial 800-579-2543 (for U.S. callers) or 785-424-1789 (for callers outside the U.S.) and enter the conference ID: CLOVQ324
- Webcast: A live and archived webcast of the conference call will be accessible from the Investor Relations section of Clover Health’s website at https://investors.cloverhealth.com/ for 12 months
About Clover Health:
Clover Health (Nasdaq: CLOV) is a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare. This includes a health equity-based focus on seniors who have historically lacked access to affordable, high-quality healthcare. Our strategy is powered by our software platform, Clover Assistant, which is designed to aggregate patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic disease. For our members, we provide PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on our flagship wide-network, high-choice PPO plans. For healthcare providers outside Clover Health's Medicare Advantage plan, we aim to extend the benefits of our data-driven technology platform to a wider audience via our subsidiary, Counterpart Health, and to enable enhanced patient outcomes and reduced healthcare costs on a nationwide scale. Clover Health has published data demonstrating the technology’s impact on Medication Adherence, as well as the earlier identification and management of Diabetes and Chronic Kidney Disease.
Press Contact:
Andrew Still-Baxter
press@cloverhealth.com
Investor Relations Contact:
Ryan Schmidt
investors@cloverhealth.com
FAQ
When will Clover Health (CLOV) report Q3 2024 earnings?
How can I access Clover Health's (CLOV) Q3 2024 earnings call?
How long will Clover Health's (CLOV) Q3 2024 earnings webcast be available?
